About AviGenics

About company

AviGenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases and autoimmune diseases. AviGenics’ proprietary technology produces therapeutic proteins with human-like glycosylation, leading to well tolerated products with increased half-life and enhanced clinical efficacy. Using this technology, the Company has demonstrated that it can achieve commercially feasible levels of production and purification for therapeutic proteins.